Differential IFN-α/β production suppressing capacities of the leader proteins of mengovirus and foot-and-mouth disease virus

Cellular Microbiology

Volumn 12, Issue 3, 2010, Pages 310-317

  Hato, Stanleyson V ^a   Sorgeloos, Frédéric ^b   Ricour, Celine ^b   Zoll, January ^a   Melchers, Willem J G ^a   Michiels, Thomas ^b   van Kuppeveld, Frank J M ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b DE DUVE INSTITUTE   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; BACTERIAL PROTEIN; BETA INTERFERON; LEADER PROTEIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; FOOT AND MOUTH DISEASE VIRUS; GENETIC TRANSCRIPTION; IMMUNE RESPONSE; INTERFERON PRODUCTION; MENGO VIRUS; MOUSE; NONHUMAN; PRIORITY JOURNAL; VIRUS INFECTION; VIRUS VIRULENCE;

ANIMALS; CARDIOVIRUS INFECTIONS; CELL LINE; CRICETINAE; FOOT-AND-MOUTH DISEASE VIRUS; INTERFERON-ALPHA; INTERFERON-BETA; MENGOVIRUS; MICE; RECOMBINATION, GENETIC; SURVIVAL ANALYSIS; VIRAL LOAD; VIRAL PROTEINS; VIRULENCE FACTORS;

APHTHOVIRUS; CARDIOVIRUS; ENCEPHALOMYOCARDITIS VIRUS; FOOT-AND-MOUTH DISEASE VIRUS; MENGO VIRUS; RNA VIRUSES;

EID: 77950606271     PISSN: 14625814     EISSN: 14625822     Source Type: Journal    
DOI: 10.1111/j.1462-5822.2009.01395.x     Document Type: Article

References (34)

1. Bardina MV, Lidsky PV, Sheval EV, Fominykh KV, van Kuppeveld FJ, Polyakov VY, Agol VI. Mengovirus-induced rearrangement of the nuclear pore complex: hijacking cellular phosphorylation machinery. J Virol 2009, 83:3150-3161.
2. Belov GA, Evstafieva AG, Rubtsov YP, Mikitas OV, Vartapetian AB, Agol VI. Early alteration of nucleocytoplasmic traffic induced by some RNA viruses. Virology 2000, 275:244-248.
3. Belov GA, Lidsky PV, Mikitas OV, Egger D, Lukyanov KA, Bienz K, Agol VI. Bidirectional increase in permeability of nuclear envelope upon poliovirus infection and accompanying alterations of nuclear pores. J Virol 2004, 78:10166-10177.
4. Brown CC, Piccone ME, Mason PW, McKenna TS, Grubman MJ. Pathogenesis of wild-type and leaderless foot-and-mouth disease virus in cattle. J Virol 1996, 70:5638-5641.
5. Chinsangaram J, Piccone ME, Grubman MJ. Ability of foot-and-mouth disease virus to form plaques in cell culture is associated with suppression of alpha/beta interferon. J Virol 1999, 73:9891-9898.
6. Chinsangaram J, Koster M, Grubman MJ. Inhibition of 1-deleted foot-and-mouth disease virus replication by alpha/beta interferon involves double-stranded RNA-dependent protein kinase. J Virol 2001, 75:5498-5503.
7. Delhaye S, van Pesch V, Michiels T. The leader protein of Theiler's virus interferes with nucleocytoplasmic trafficking of cellular proteins. J Virol 2004, 78:4357-4362.
8. De Los Santos T, de Avila, Botton S, Weiblen R, Grubman MJ. The leader proteinase of foot-and-mouth disease virus inhibits the induction of beta interferon mRNA and blocks the host innate immune response. J Virol 2006, 80:1906-1914.
9. De Los Santos T, Diaz-San Segundo F, Grubman MJ. Degradation of nuclear factor kappa B during foot-and-mouth disease virus infection. J Virol 2007, 81:12803-12815.
10. De Los Santos T, Segundo FD, Zhu J, Koster M, Dias CC, Grubman MJ. A conserved domain in the leader proteinase of foot-and-mouth disease virus is required for proper subcellular localization and function. J Virol 2009, 83:1800-1810.
11. Devaney MA, Vakharia VN, Lloyd RE, Ehrenfeld E, Grubman MJ. Leader protein of foot-and-mouth disease virus is required for cleavage of the p220 component of the cap-binding protein complex. J Virol 1988, 62:4407-4409.
12. Guarne A, Tormo J, Kirchweger R, Pfistermueller D, Fita I, Skern T. Structure of the foot-and-mouth disease virus leader protease: a papain-like fold adapted for self-processing and eIF4G recognition. EMBO J 1998, 17:7469-7479.
13. Gustin KE, Sarnow P. Effects of poliovirus infection on nucleo-cytoplasmic trafficking and nuclear pore complex composition. EMBO J 2001, 20:240-249.
14. Gustin KE, Sarnow P. Inhibition of nuclear import and alteration of nuclear pore complex composition by rhinovirus. J Virol 2002, 76:8787-8796.
15. Hato SV, Ricour C, Schulte BM, Lanke KH, de Bruijni M, Zoll J. The mengovirus leader protein blocks interferon-alpha/beta gene transcription and inhibits activation of interferon regulatory factor 3. Cell Microbiol 2007, 9:2921-2930.
16. Jang SK, Krausslich HG, Nicklin MJ, Duke GM, Palmenberg AC, Wimmer E. A segment of the 5′ nontranslated region of encephalomyocarditis virus RNA directs internal entry of ribosomes during in vitro translation. J Virol 1988, 62:2636-2643.
17. Kaminski A, Belsham GJ, Jackson RJ. Translation of encephalomyocarditis virus RNA: parameters influencing the selection of the internal initiation site. EMBO J 1994, 13:1673-1681.
18. Kirchweger R, Ziegler E, Lamphear BJ, Waters D, Liebig HD, Sommergruber W. Foot-and-mouth disease virus leader proteinase: purification of the Lb form and determination of its cleavage site on eIF-4 gamma. J Virol 1994, 68:5677-5684.
19. Krausslich HG, Nicklin MJ, Toyoda H, Etchison D, Wimmer E. Poliovirus proteinase 2A induces cleavage of eucaryotic initiation factor 4F polypeptide p220. J Virol 1987, 61:2711-2718.
20. Lidsky PV, Hato S, Bardina MV, Aminev AG, Palmenberg AC, Sheval EV. Nucleocytoplasmic traffic disorder induced by cardioviruses. J Virol 2006, 80:2705-2717.
21. Mason PW, Piccone ME, McKenna TS, Chinsangaram J, Grubman MJ. Evaluation of a live-attenuated foot-and-mouth disease virus as a vaccine candidate. Virology 1997, 227:96-102.
22. Neznanov N, Chumakov KM, Neznanova L, Almasan A, Banerjee AK, Gudkov AV. Proteolytic cleavage of the p65-RelA subunit of NF-kappaB during poliovirus infection. J Biol Chem 2005, 280:24153-24158.
23. Park N, Katikaneni P, Skern T, Gustin KE. Differential targeting of nuclear pore complex proteins in poliovirus-infected cells. J Virol 2008, 82:1647-1655.
24. Paul S, Michiels T. Cardiovirus leader proteins are functionally interchangeable and have evolved to adapt to virus replication fitness. J Gen Virol 2006, 87:1237-1246.
25. van Pesch V, van Eyll O, Michiels T. The leader protein of Theiler's virus inhibits immediate-early alpha/beta interferon production. J Virol 2001, 75:7811-7817.
26. Piccone ME, Rieder E, Mason PW, Grubman MJ. The foot-and-mouth disease virus leader proteinase gene is not required for viral replication. J Virol 1995, 69:5376-5382.
27. Piccone ME, Chen HH, Roos RP, Grubman MJ. Construction of a chimeric Theiler's murine encephalomyelitis virus containing the leader gene of foot-and-mouth disease virus. Virology 1996, 226:135-139.
28. Porter FW, Palmenberg AC. Leader-induced phosphorylation of nucleoporins correlates with nuclear trafficking inhibition by cardioviruses. J Virol 2009, 83:1941-1951.
29. Porter FW, Bochkov YA, Albee AJ, Wiese C, Palmenberg AC. A picornavirus protein interacts with Ran-GTPase and disrupts nucleocytoplasmic transport. Proc Natl Acad Sci USA 2006, 103:12417-12422.
30. Ricour C, Delhaye S, Hato SV, Olenyik TD, Michel B, van Kuppeveld FJ. Inhibition of mRNA export and dimerization of interferon regulatory factor 3 by Theiler's virus leader protein. J Gen Virol 2009, 90:177-186.
31. Romanova LI, Lidsky PV, Kolesnikova MS, Fominykh KV, Gmyl AP, Sheval EV. Antiapoptotic activity of the cardiovirus leader protein, a viral 'security' protein. J Virol 2009, 83:7273-7284.
32. Ryan MD, Belsham GJ, King AM. Specificity of enzyme-substrate interactions in foot-and-mouth disease virus polyprotein processing. Virology 1989, 173:35-45.
33. Zoll J, Galama JM, van Kuppeveld FJ, Melchers WJ. Mengovirus leader is involved in the inhibition of host cell protein synthesis. J Virol 1996, 70:4948-4952.
34. Zoll J, Melchers WJ, Galama JM, van Kuppeveld FJ. The mengovirus leader protein suppresses alpha/beta interferon production by inhibition of the iron/ferritin-mediated activation of NF-kappa B. J Virol 2002, 76:9664-9672.